ARTICANZ - Beta (ver 0.91)

Annotated Registry of Trials in Cancer, Australia and New Zealand Ed. - Results - target/HDAC-inhibitor

Search results

target/HDAC-inhibitor
5 trial(s) found.
NCT07244705
NCT05694936
NCT03838042
ACTRN12616001021460
ACTRN12616001187437
Filters
HDAC
100%
PD-1
40%
PD-1/PD-L1
40%
EGFR
40%
VEGF
20%
ALK
20%
AXL
20%
BCR-ABL1
20%
CDK4
20%
CDK6
20%
CRAF
20%
ERBB2
20%
FGFR1
20%
FGFR1/2/3
20%
FGFR2
20%
FGFR3
20%
FGFR4
20%
FLT3
20%
IGF1R
20%
KIT
20%
MEK
20%
MET
20%
PARP
20%
PDGFR
20%
PDGFRA
20%
RAF
20%
RET
20%
ROS1
20%
SRC
20%
VEGFR
20%
VEGFR2
20%
YES1
20%
mTOR
20%
mTORC1
20%
proteasome
20%




















 






























	
		
	

    

        

			ARTICANZ (Annotated Registry of Trials in Cancer, Australia/NZ Edition; ARTificial Intelligence-enhanced CANcer trial information database) provides information about cancer drug trials in Australia and New Zealand as a free, open-information platform. Please note the following:

			
    
			
  • Data Accuracy: While ARTICANZ strives to maintain accurate and up-to-date information through regular weekly updates and specialist review, we cannot guarantee the complete accuracy, reliability, or timeliness of all data. Information may change between updates.
    • 
			
			
  • Not Medical Advice: The information provided by ARTICANZ is for informational purposes only and should not be considered medical advice. All clinical decisions should be made in consultation with qualified healthcare professionals.
    • 
			
			
  • No Warranty: ARTICANZ is provided "as is" without any warranties, expressed or implied. We disclaim all liability for any damages arising from the use of or inability to use this platform.
    • 
			
			
  • External Links: ARTICANZ may contain links to external websites. We are not responsible for the content or privacy practices of these sites.
    • 
			
			


			By using ARTICANZ, you acknowledge that you have read and understood this disclaimer.
			
		

        

            
The ARTICANZ platform and its contents are made available under the Creative Commons Attribution 4.0 International License (CC BY 4.0).

            
            
Users are free to:

            
    
                
  • Share — copy and redistribute the data in any medium or format
    • 
                
  • Adapt — remix, transform, and build upon the data
    • 
                
  • Use the data for any purpose, including commercial use
    • 
            

            
            
Under the following terms:

            
    
                
  • Attribution — You must give appropriate credit to ARTICANZ, provide a link to the license, and indicate if changes were made
    • 
                
  • No additional restrictions — You may not apply legal terms or technological measures that legally restrict others from doing anything the license permits
    • 
            

            
            
Platform developed and currently maintained by Dr. Frank Lin and the ARTICANZ team.